Medicare s s 2009 eprescribing Program
|
|
|
- Joella Dickerson
- 6 years ago
- Views:
Transcription
1 Medicare s s 2009 eprescribing Program Daniel Green, MD, FACOG Medical Officer, Quality Measurement Health Assessment Group Office of Clinical Standards and Quality Centers for Medicare & Medicaid Services Baltimore, MD
2 Overview Review MIPPA provisions relevant to new eprescribing incentive. Review eprescribing measure in 2008 PQRI Review implementation schedule for 2009 PQRI and eprescribing incentive.
3 MIPPA Legislation PQRI The Medicare Improvements for Patients and Providers Act (MIPPA), passed in July 2008, contains several new authorities and requirements for quality reporting and PQRI for 2009 and beyond. Section 132 contains the new electronic prescribing incentive provisions.
4 MIPPA Legislation Successful Electronic Prescriber, Section 132 The MIPPA provides for a 2% incentive payment to eligible professionals who successfully prescribe (as defined by the statute) their patient s medications electronically beginning in The legislation specifically refers to applicable electronic prescribing quality measures (i.e., eprescribing measure #125).
5 MIPPA Legislation Successful Electronic Prescriber, Section 132 (cont) eprescribing measure will be removed from PQRI for 2009 and added to the eprescribing incentive program. The Secretary has the authority to update the specifications of the electronic prescribing measure in the future.
6 2008 PQRI eprescribing Measure Electronic Prescribing Structural Measure (measure #125) qualifies as one of three required measures in PQRI to earn an incentive payment. Requirement for 2008 PQRI is to report the measure on 80% or more of eligible patients. No separate incentive for successful eprescribing in 2008 PQRI.
7 Electronic Prescribing Measure in 2008 PQRI If you have not adopted an electronic prescribing system that meets the specifications of the measure, you cannot report on this measure. The measure is intended to be reported for EVERY patient visit in the denominator.
8 Qualified Electronic Prescribing Systems Measure #125 The measure assesses an eligible professional s use of electronic prescribing using a qualified system. As a qualified system, the program must be able to perform the following tasks: Generate a medication list incorporating electronic data received from pharmacies or PBMs (if available) Select medications Transmit prescriptions electronically and conduct safety alerts
9 Qualified Electronic Prescribing Systems Measure #125 (cont) Conduct safety alerts Automated prompts that offer information on the drug being prescribed Potential inappropriate dose or route of administration of the drug, drug-drug interactions Allergy concerns Warnings and cautions Provide information on lower cost alternatives (if any). (Tiered formulary information, if available, would satisfy this requirement for 2009) Provide information on formulary or tiered formulary medications, patient eligibility and authorization requirements received electronically from the patient s drug plan (if available).
10 Additional erx System Requirements The System must employ the current Part D standards for the functionalities they provide
11 Part D Standards The standards refer to the version of messaging that the eprescribing program uses to send the information over the prescription network. It is similar to an update of a particular software product (i.e. Word 97 vs. Word 2003).
12 How eprescribing Works An eligible professional decides to order a prescription for a patient. The prescription is entered into an eprescribing program and is transmitted to the desired pharmacy. Communication also occurs between the pharmacy benefit manager and the physician.
13 eprescribing Communication Professional PBM Pharmacy
14 SureScripts-RxHub Network where the prescription communication or messaging travels between the 3 entities involved in eprescribing (i.e., the professional, pharmacy and PBM). Approximately 90% of US prescriptions use the SureScripts-RxHub network. eprescribing vendors using the SureScripts- RxHub network must be certified by SureScripts-RxHub.
15 Determining if your System is Part D Compliant Vendors listed on the SureScripts website, meet the 2009 Part D standards for the functions they provide.
16 Qualified eprescribing Systems for 2009 If an eprescribing system is not on the SureScripts network, a potential customer should look at the Part D standards on the CMS website and check with the product s vendor. You must HAVE and USE a qualified eprescribing system. If purchasing a system, have the vendor demonstrate each functionality described in the measure
17 Earning 2% Through eprescribing Patient must have an encounter with one of these CPT or G-codes: 90801, 90802, 90804, 90805, 90806, 90807, 90808, 90809, 92002, 92004, 92012, 92014, 96150, 96151, 96152, 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99241, 99242, 99243, 99244, 99245, 99381, 99382, 99383, 99384, 99385, 99386, 99387, 99391, 99392, 99393, 99394, 99395, 99396, 99397, G0101, G0108, G0109
18 Earning 2% Through eprescribing Report on all eligible patients to ensure success. 3 G-codes can be used in this measure: G8443 G8445 G8446
19 eprescribing G-codes G8443 All prescriptions created during the encounter were generated using a qualified e-prescribing system. OR G8445 No prescriptions were generated during the encounter. Provider does have access to a qualified e-prescribing system. OR G8446 Provider does have access to a qualified eprescribing system. Some or all prescriptions generated during the encounter were printed or phoned in as required by state or federal law or regulations, patient request or pharmacy system being unable to receive electronic transmission; OR because they were for narcotics or other controlled substances.
20 Measure #125 for 2009 eprescribing The Secretary may change the measure specifications until December 31, 2008
21 Additional Information CMS has an eprescribing section page on the PQRI website at This section will contain information on: The MIPPA legislation A fact sheet describing the MIPPA eprescribing incentive provisions Part D standards eprescribing Made Simple Other documents/instructions
22 CCHIT CCHIT currently certifies EHRs which contain eprescribing modules CCHIT certified systems meet the functionality requirements of the measure Some of the erx modules may be available for purchase separately.
23 CCHIT (cont) Some products are designated partners of 2008 CCHIT certified EHRs. These partners would meet the functionality requirements CCHIT expects to review stand-alone systems for certification starting in mid-2009.
24 Reporting of the eprescribing Measure as Described Under the MIPPA Statute Successful reporting is defined as reporting the measure on at least 50% of eligible patients. Limitation: CPT codes that make up the denominator of the erx measure MUST account for at least 10% of the provider s total allowed charges for Medicare Part B covered services during the reporting period.
25 Incentives for Successful eprescribing Under MIPPA A 2% payment incentive for successful use of eprescribing is available for 2009 & In 2011 and 2012 the payment incentive drops to 1% of covered Medicare Part B charges. In 2013 the incentive drops to 0.5% of the covered Medicare Part B charges.
26 Future Penalties for Not Electronically Prescribing Eligible professionals who are not successfully using electronic prescribing by 2012 will be penalized 1% of their covered Medicare Part B charges. This means that these providers will be paid at 99% for their covered Medicare Part B fee schedule services.
27 Future Penalties for Not Electronically Prescribing (cont) Fee reduction is prospective, providers will have to electronically prescribe by a date to be determined to be sure their fees are not reduced in This date will not be before Hardship exemption.
28 Future Penalties for Not Electronically Prescribing (cont) In % deducted from their covered Medicare Part B services. Professionals will be paid at 98.5% of the physician fee schedule for covered services. In 2014 and beyond penalty will increase to 2%. Professionals will receive 98% of the physician fee schedule for the covered services they provide.
29 Part D Information The Secretary has the authority to change the requirements for successful eprescribing in the future. The MIPPA legislation allows for future use of Part D data (i.e., a specific number of electronically written prescriptions) in lieu of claims-based reporting by eligible professionals.
30 Implementation Schedule for 2009 PQRI and eprescribing Incentive 2009 PQRI 2009 PFS Rule posted July 1, 2008; comment period for proposed rule ended 8/29/08. MIPPA provisions enacted July 15, Electronic Prescribing Incentive Details of the program were Published in the Physician Fee Schedule Final Rule section of the Federal Register in November, 2008
31 Additional PQRI Resources For more information on PQRI and eprescribing, please visit our website at: Thank you!
PCC EHR eprescribing Best Practices
PCC EHR eprescribing Best Practices Lauren Gluck Physician's Computer Company PCC Users' Conference July, 2013 Goal of this Course Using the eprescribing feature in PCC EHR gives you many flexible and
The Real-Time Benefit Check Key to Closing the Gaps in Eligibility Driven Formulary. Tony Schueth Chief Executive Officer & Managing Partner
The Real-Time Benefit Check Key to Closing the Gaps in Eligibility Driven Formulary Tony Schueth Chief Executive Officer & Managing Partner Eligibility-Informed Formulary Information Flow Current Workflow
Employers Forum of Indiana and epa. March 23, 2016
Employers Forum of Indiana and epa March 23, 2016 Copyright Copyright 2016 by 2016 Surescripts, by Surescripts, LLC. All LLC. rights All reserved. rights reserved. Prior authorization, the problem we are
NCVHS. May 15, Dear Madam Secretary,
NCVHS May 15, 2014 Honorable Kathleen Sebelius Secretary, Department of Health and Human Services 200 Independence Avenue, S.W. Washington, D.C. 20201 Re: Findings from the February 2014 NCVHS Hearing
Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]
![Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]](/thumbs/88/115848006.jpg "Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]")
January 25, 2019 Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-4180-P P.O. Box 8013 Baltimore, MD 21244-8013 Re: Modernizing
January 16, Submitted electronically via:
Submitted electronically via: http://www.regulations.gov The Honorable Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-4182-P
erx Tips and Tricks Lauren Gluck User's Conference 2015
erx Tips and Tricks Lauren Gluck User's Conference 2015 Table of Contents What is the Take Away? 1 Outline 1 What is the Take Away? This course will focus on some eprescribing best practices that can help
Project: Surescripts Prescriptions Benefits - Eligibility & Formulary
Background: Electronic health records (EHRs) can provide a host of benefits to providers and their patients. How much value can be derived from EHRs depends widely on how they are used. The Prescriber
Real-Time Pharmacy Benefit Inquiry: The Time is Right for More Informed Medication Decisions
Real-Time Pharmacy Benefit Inquiry: The Time is Right for More Informed Medication Decisions PBMI Annual Drug Benefit Conference March 6, 2017 PRESENTERS: Anthony Schueth, Point-of-Care Partners Julia
SecurityBlue HMO. Link to Specific Guidance Regarding Exceptions and Appeals
SecurityBlue HMO Conditions and Limitations Potential for Contract Termination Disenrollment Rights and Instructions Exceptions, Prior Authorization, Appeals and Grievances Out-of-Network Coverage Quality
Martin s Point Generations Advantage Policy and Procedure Form
Martin s Point Generations Advantage Policy and Procedure Form Policy #: PartD.923 Effective Date: 4/16/10 Policy Title: Part D Transition Policy Section of Manual: Medicare Prescription Drug Benefit Manual
BlueRx PDP. Link to Specific Guidance Regarding Exceptions and Appeals
BlueRx PDP Conditions and Limitations Potential for Contract Termination Disenrollment Rights and Instructions Exceptions, Prior Authorization, Appeals and Grievances Out-of-Network Coverage Quality Assurance
Payment Adjustments & Hardship Exceptions Tipsheet for Eligible Professionals Last Updated: August, 2012
Overview Payment Adjustments & Hardship Exceptions Tipsheet for Eligible Professionals Last Updated: August, 2012 As part of the American Recovery and Reinvestment Act of 2009 (ARRA), Congress mandated
MEDEHR Certified Version 2.0 New Feature
052215 EHR NEWS MEDEHR Certified Version 2.0 New Feature MEDTRON is continually adding new features (enhancements) to MEDEHR. Outlined below are some of the new features moving to production in the coming
I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:
I. PURPOSE The purpose of the Policy and Procedure is to ensure necessary continuity of treatment and to provide adequate time and transition process to introduce the enrollee and their prescribing physician
National Provider Call:
National Provider Call: Physician Quality Reporting System (Physician Quality Reporting) and Electronic Prescribing (erx) Incentive Program May 22, 2012 Disclaimers This presentation was current at the
RELIEF FOR ELIGIBLE PROFESSIONALS? PROPOSED STAGE 2 MEANINGFUL USE RULE INCLUDES IMPORTANT (POTENTIAL) EXCEPTIONS [OBER KALER]
![RELIEF FOR ELIGIBLE PROFESSIONALS? PROPOSED STAGE 2 MEANINGFUL USE RULE INCLUDES IMPORTANT (POTENTIAL) EXCEPTIONS [OBER KALER]](/thumbs/88/116116176.jpg "RELIEF FOR ELIGIBLE PROFESSIONALS? PROPOSED STAGE 2 MEANINGFUL USE RULE INCLUDES IMPORTANT (POTENTIAL) EXCEPTIONS [OBER KALER]")
RELIEF FOR ELIGIBLE PROFESSIONALS? PROPOSED STAGE 2 MEANINGFUL USE RULE INCLUDES IMPORTANT (POTENTIAL) EXCEPTIONS Publication RELIEF FOR ELIGIBLE PROFESSIONALS? PROPOSED STAGE 2 MEANINGFUL USE RULE INCLUDES
2019 Transition Policy
2019 Number: 5.8 Prescription Drug Replaces: 5.8 v.2018 Cross 5.1.2 Transition Fill Monitoring Procedure References: Purpose: To provide guidance on the transition process for new or current Plan members
2018 Medicare Part D Transition Policy
Regulation/ Requirements Purpose Scope Policy 2018 Medicare Part D Transition Policy 42 CFR 423.120(b)(3) 42 CFR 423.154(a)(1)(i) 42 CFR 423.578(b) Medicare Prescription Drug Benefit Manual, Chapter 6,
Electronic Prior Authorization Initiatives at the Point of Care: Moving the Industry Forward
Electronic Prior Authorization Initiatives at the Point of Care: Moving the Industry Forward Friday, April 20 th from 11:45am to 12:45am Marc Nyarko, Humana Bruce Wilkinson, CVS Caremark Roger Pinsonneault,
[F5] Leveraging Technology for Patient- Level Formulary & Benefit Information at the Point of Care
![[F5] Leveraging Technology for Patient- Level Formulary & Benefit Information at the Point of Care](/thumbs/88/117110284.jpg "[F5] Leveraging Technology for Patient- Level Formulary & Benefit Information at the Point of Care")
[F5] Leveraging Technology for Patient- Level Formulary & Benefit Information at the Point of Care Michael J. Anderson, PharmD UnitedHealthcare Medicare & Retirement Kimberly Hansen UnitedHealthcare Anthony
Extra Time to Succeed in Meaningful Use, A New CMS FAQ Confirms
IT Strategy Council Extra Time to Succeed in Meaningful Use, A New CMS FAQ Confirms Naomi Levinthal Consultant LevinthN@advisory.com Anantachai (Tony) Panjamapirom Consultant PanjamaT@advisory.com 2445
PURPOSE OF THE POLICY STATEMENT OF THE POLICY PROCEDURES
PURPOSE OF THE POLICY The purpose of this policy is to describe Health Alliance s process for transitions and ensure that continued drug coverage is provided to new and current Part D members. The transition
Medicare Part D Transition Policy
Medicare Part D Transition Policy Transition Policy for New and Current Enrollees of our Medicare Part D Prescription Drug Plan PURPOSE: Simply Healthcare Plans, Inc. must maintain an appropriate transition
The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use. Presented by Daniel Tomaszewski Pharmd, PhD
The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use Presented by Daniel Tomaszewski Pharmd, PhD 1 Medical Vs. Pharmacy Coverage Medical Insurance Managed by an Insurance
Medicare Part D Transition Policy CY 2018 HCSC Medicare Part D
Contract: H0107, H0927, H1666, H3251, H3822, H3979, H8133, H8634, H8554, S5715 Policy Name: Medicare Formulary Transition Purpose: This procedure describes the standard process Health Care Service Corporation
Update on Medicare s Physician Incentive Programs
Physician Practice Roundtable Update on Medicare s Physician Incentive Programs An Overview of the Physician Quality Reporting System (PQRS), Value-Based Payment Modifier (VBPM), and Electronic Prescribing
2019 Transition Policy and Procedure
2019 Transition Policy and Procedure POLICY Steward Health Choice Generations (SHCG) provides a Part D drug transition process in order to prevent enrollee medication coverage gaps. SHCG s transition process
Medicare Transition POLICY AND PROCEDURES
Medicare Transition POLICY AND PROCEDURES POLICY The Plan will maintain an appropriate transition process, consistent with 42 CFR 423.120(b)(3), Chapter 6 of the Medicare Prescription Drug Benefit Manual
Contract Summary. OptumRx Administrative Services, LLC
Attachment C Contract Summary OptumRx Administrative Services, LLC Subcontractors This contract includes the following subcontractors or pass through to other providers. Name Service(s) Amount Interpreting
A Guide to Healthcare Buzzwords and What They Mean: Part One (A through L)
A Guide to Healthcare Buzzwords and What They Mean: Part One (A through L) Welcome to our guide to Healthcare Buzzwords! ACO An acronym for Accountable Care Organization, an ACO is a model of healthcare
There is nothing wrong with change, if it is in the right direction Winston Churchil
Changes Changes 2012 2012 There is nothing wrong with change, if it is in the right direction Winston Churchill New tools provided by the Affordable Care Act are strengthening the Obama administration
Y0076_ALL Trans Pol
Policy Title: Medicare Part D Transition Policy Policy Number: PCM-2018 TB Policy Owner: Antonio Petitta, Vice President Pharmacy Care Management Department(s): Pharmacy Care Management Effective Date:
REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax:
REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax: Address: Fax Number: Aetna Better Health of Virginia (HMO SNP) 1-877-270-0148 Part D Coverage Determination
HIPAA Readiness Disclosure Statement
HIPAA Readiness Disclosure Statement Blue Cross of California and its affiliates have been diligently following the evolution of the Administrative Simplification provisions of the Health Insurance Portability
Automating Specialty Pharmacy: Identifying Gaps
Automating Specialty Pharmacy: Identifying Gaps Kevin James, R.Ph., MBA VP, Payer Strategy US Bioservices Jeff Spafford President and CEO AssistRx Tony Schueth, M.S. CEO & Managing Partner Point-of-Care
Formulary Services EULA
Formulary Services EULA Formulary Services. Allscripts is reliant on Surescripts in facilitating the provision of the Formulary Services described in Schedule A (the Formulary Services Terms ). If Surescripts
Regulatory/Legislative Update
Regulatory/Legislative Update Gain Real-Time Updates on State and Federal Legislative Advancements May 23, 2017 Panelists Nicole Russell Manager, Government Affairs NCPDP Michele V. Davidson, R.Ph. Senior
2012 Medicare Physician Fee Schedule Final Rule Summary
2012 Medicare Physician Fee Schedule Final Rule Summary On November, 1, 2011, the Centers for Medicare and Medicaid Services (CMS) posted the final Medicare Physician Fee Schedule (MPFS) for 2012. It is
E-PRESCRIBING SERVICES TERMS
E-PRESCRIBING SERVICES TERMS Certain software licensed by Allscripts Healthcare, LLC ( Allscripts ) may allow Client to access E- Prescribing Services (as defined below) to route prescriptions, access
All Medicare Advantage Products with Part D Benefits
SUBJECT: TYPE: DEPARTMENT: Transition Process For Medicare Part D Departmental Pharmacy Care Management EFFECTIVE: 1/2017 REVISED: APPLIES TO: All Medicare Advantage Products with Part D Benefits POLICY
Best Practice Recommendation for
Best Practice Recommendation for Exchanging & Processing about Pharmacy Benefit Management Version 020915a Issue Date Version Explanation 10-20-2014 First Release 02-09-15 Clarify language under Health
Compliance Program. Health First Health Plans Medicare Parts C & D Training
Compliance Program Health First Health Plans Medicare Parts C & D Training Compliance Training Objectives Meeting regulatory requirements Defining an effective compliance program Communicating the obligation
Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - Pharmacy
Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - In this Section there are references unique to Blue Essentials, Blue Advantage HMO and Blue Premier. These network specific
REPORT 8 OF THE COUNCIL ON MEDICAL SERVICE (I-11) Administrative Simplification in the Physician Practice (Reference Committee J) EXECUTIVE SUMMARY
REPORT OF THE COUNCIL ON MEDICAL SERVICE (I-) Administrative Simplification in the Physician Practice (Reference Committee J) EXECUTIVE SUMMARY In its ongoing effort to address health care costs that do
Update: Electronic Transactions, HIPAA, and Medicare Reimbursement
McMahon HIPAA Update 521 Pain Physician. 2003;6:521-525, ISSN 1533-3159 Practice Management Update: Electronic Transactions, HIPAA, and Medicare Reimbursement Erin Brisbay McMahon, JD Physician practices
Track III-A. Creating Relationships with Prescription Drug Plans and Managed Care Organizations
Track III-A Creating Relationships with Prescription Drug Plans and Managed Care Organizations David L. Ralston Legal Director Schering-Plough Corporation Part D is for Dollars Follow the money by tracing
Jill Rosenthal, MD, MA, MPH, FACOEM SVP, Chief Medical Officer Zenith Insurance Company
Jill Rosenthal, MD, MA, MPH, FACOEM SVP, Chief Medical Officer Zenith Insurance Company The prescription drug (Rx) share of total workers compensation (WC) medical costs for Accident Year 2014 = 17% Rx
Classification: Clinical Department Policy Number: Subject: Medicare Part D General Transition
Classification: Clinical Department Policy Number: 3404.00 Subject: Medicare Part D General Transition Effective Date: 01/01/2019 Process Date Revised: 07/20/2018 Date Reviewed: 05/29/2018 POLICY STATEMENT:
Contract Summary. OptumRx Administrative Services, LLC
Contract Summary OptumRx Administrative Services, LLC Subcontractors This contract includes the following subcontractors or pass through to other providers. Name Service(s) Amount Interpreting Services
Values Accountability Integrity Service Excellence Innovation Collaboration
n04231 Medicare Part D Transition and Emergency Fill Policy Values Accountability Integrity Service Excellence Innovation Collaboration Abstract Purpose: The Medicare Part D Transition and Emergency Fill
Contract Pharmacy Relationships
Contract Pharmacy Relationships What is a contract pharmacy? 1 What is a contract pharmacy? Dispenses drugs to FQHC patients on behalf of FQHC Contract between FQHC and pharmacy Typically pharmacy not
Compliance and Fraud, Waste, and Abuse Awareness Training. First Tier, Downstream, and Related Entities
Compliance and Fraud, Waste, and Abuse Awareness Training First Tier, Downstream, and Related Entities 1 Course Outline Overview Purpose of training Effective Compliance program Definition of Fraud, Waste,
Medicare Advantage Part D Pharmacy Policy
Page 1 of 27 DISCLAIMER NOTICE: The purpose of this policy is to provide guidance for benefit and coverage determinations only. Benefit and coverage determinations are subject to the contractual limitations
Current Status Of Legislation on Quality Bench Marks
Conflicts of Interest Current Status Of Legislation on Quality Bench Marks None Sean P. Roddy, MD Albany, NY Reason For Quality Measures Progressive increase in healthcare costs under the fee-for-service
PRESCRIPTION MONITORING PROGRAM MODEL ACT
Alliance of States with Prescription Monitoring Programs and National Association of State Controlled Substances Authorities Background information on the PRESCRIPTION MONITORING PROGRAM MODEL ACT October
REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax:
REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax: Address: BlueCross BlueShield of Western New York P.O. Box 80 Buffalo, NY 14204 Attn: Pharmacy
APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1
APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 DECEMBER 2016 TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 DECEMBER 2016 APPENDIX B: VENDOR DRUG PROGRAM Table of
Texas Vendor Drug Program. Drug Addition Process. Effective Date. December 2017
Texas Vendor Drug Program Drug Addition Process Effective Date December 2017 This is a working document to provide a resource to interested internal and external stakeholders. Questions or comments regarding
Implement a definition of negotiated price to include all pharmacy price concessions.
NCPA Analysis of Medicare Part D Pharmacy DIR Fee Reform Policy Proposal and Other Policies Impacting Community Pharmacies in the CMS Proposed Rule, Modernizing Part D and Medicare Advantage to Lower Drug
Center for Medicaid and State Operations. March 22, 2007 SMDL # Dear State Medicaid Director:
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop S2-26-12 Baltimore, Maryland 21244-1850 Center for Medicaid and State Operations March
Information Maintained by the Office of Code Revision Indiana Legislative Services Agency IC Chapter 22. Pharmacy Audits
Information Maintained by the Office of Code Revision Indiana Legislative Services Agency IC 25-26-22 Chapter 22. Pharmacy Audits IC 25-26-22-1 Definitions applicable to chapter Sec. 1. The definitions
Summary of 2017 Medicare Part D Final Call Letter
Summary of 2017 Medicare Part D Final Call Letter On April 4, 2016, the Centers for Medicare & Medicaid Services (CMS) issued the 2017 Medicare Advantage Capitation Rates and Medicare Advantage and Part
MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE. Reporting Requirements: Audit Preparedness for PDPs and Manufacturers
MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE Reporting Requirements: Audit Preparedness for PDPs and Manufacturers Polaris Management Partners 8:30 9:30am Concurrent Breakout Session AGENDA
HIPAA Electronic Transactions & Code Sets
P R O V II D E R H II P A A C H E C K L II S T Moving Toward Compliance The Administrative Simplification Requirements of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) will have
THIRD PARTY REIMBURSEMENT OF COVERED ENTITIES: MANUFACTURERS PERSPECTIVE
THIRD PARTY REIMBURSEMENT OF COVERED ENTITIES: MANUFACTURERS PERSPECTIVE Donna Lee Yesner Morgan Lewis and Bockius Phone : 202.739.5887 Email: dyesner@morganlewis.com www.morganlewis.com BACKGROUND In
TRANSITION POLICY. Members Health Insurance Company
Members Health Insurance Company TRANSITION POLICY POLICY The Company will maintain an appropriate transition process, consistent with 42 CFR 423.120(b)(3), Chapter 6 of the Medicare Prescription Drug
Texas Vendor Drug Program Pharmacy Provider Procedure Manual
Texas Vendor Drug Program Pharmacy Provider Procedure Manual System Requirements May 2018 The Pharmacy Provider Procedure Manual (PPPM) is available online at txvendordrug.com/about/policy/manual. ` Table
Important Information about our prescription drug program
under your prescription drug benefit. Our records indicate a drug prescribed for you is affected by a prior authorization change. Changes to prior authorization requirements As of , the drug(s)
2012 Checklist for Community Pharmacy. Medicare Part D-Related Information
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2012 Checklist for Community Pharmacy Medicare Part D-Related Information Medicare Part D Valid Prescriber Identifiers For 2012, CMS will continue to permit the
Glossary. Last Reviewed 11/10/14
Glossary ACCC ACA ACS AHFS AHRQ AMA APC Association of Community Cancer Centers Affordable Care Act American Cancer Society American Hospital Formulary Service Agency for Healthcare Research and Quality
Medicare Prescription Drug, Improvement and Modernization Act
International Journal of Health Research and Innovation, vol. 1, no. 2, 2013, 13-18 ISSN: 2051-5057 (print version), 2051-5065 (online) Scienpress Ltd, 2013 Medicare Prescription Drug, Improvement and
21 - Pharmacy Services
21 - Pharmacy Services The role of Health Plan of Nevada s (HPN) Pharmacy Services is to evaluate and determine the appropriateness of quality drug therapy while maintaining and improving therapeutic outcomes.
Sender's Direct Phone (202) Sender's Direct Facsimile (202) MEMORANDUM
PHILIP C. OLSSON RICHARD L. FRANK DAVID F. WEEDA (1948-2001) DENNIS R. JOHNSON ARTHUR Y. TSIEN JOHN W. BODE* STEPHEN D. TERMAN MARSHALL L. MATZ MICHAEL J. O'FLAHERTY DAVID L. DURKIN NEIL F. O'FLAHERTY
Glossary of Terms (Terms are listed in Alphabetical Order)
Glossary of Terms (Terms are listed in Alphabetical Order) Access Access refers to the availability and location of pharmacies that participate in the network that serves your pharmacy benefit plan. Acute
The Impact of Standards & Pharmacy Informatics
Presented by NCPDP and HIMSS for the Pharmacy Informatics Community The Impact of Standards & Pharmacy Informatics September 20, 2012 Lisa Ashton, Pharm.D. Office of Health Information Integrity, California
Highlights from the proposed rule include the following:
Proposed Physician Fee Schedule for CY 2011: Initial Summary of Issues of Concern to ASCO Members On June 25, 2010, the Centers for Medicare and Medicaid Services (CMS) displayed the proposed rule for
Subject: Indiana Health Coverage Programs (IHCP) Transition to the National Council for Prescription Drug Programs (NCPDP) Version 5.
P R O V I D E R B U L L E T I N B T 2 0 0 3 6 1 S E P T E M B E R 1 9, 2 0 0 3 To: All Pharmacy Providers Subject: Indiana Health Coverage Programs (IHCP) Transition to the National Council for Prescription
Chapter 10 Prescriptions Benefits and Drug Formulary
10 Prescription Benefits and Drug Formulary Health Choice Generations is a Medicare Advantage Special Needs Plan (SNP) with Medicare Part D Prescription Drug Coverage. Medicare Part D drugs covered by
Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training. Developed by the Centers for Medicare & Medicaid Services
Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training Developed by the Centers for Medicare & Medicaid Services Important Notice This training module consists of two parts:
eprescribing s Formulary and Benefits: At a Crossroad By Tony Schueth, Editor-in-Chief
eformulary eprescribing s Formulary and Benefits: At a Crossroad By Tony Schueth, Editor-in-Chief Studies have shown that much of the value proposition for eprescribing lies in providing formulary & benefits
Payment Adjustments & Hardship Exceptions for Eligible Hospitals and CAHs Last Updated: March 2014
Payment Adjustments & Hardship Exceptions for Eligible Hospitals and CAHs Last Updated: March 2014 Overview As part of the American Recovery and Reinvestment Act of 2009 (ARRA), Congress mandated payment
June 25, Seema Verma Administrator Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244
Seema Verma Administrator Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 RE: Price Transparency Request for Information (RFI); CMS 1694 P, Medicare Program; Hospital
NCPDP Update. Review of NCPDP Task Group Efforts and Use Cases for Real-Time Benefit Inquiry Standard. May 23, 2017
NCPDP Update Review of NCPDP Task Group Efforts and Use Cases for Real-Time Benefit Inquiry Standard May 23, 2017 Catherine C Graeff CEO, Sonora Advisory Group, LLC Active in NCPDP since 1988 - as a member,
Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training
Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training Developed by the Centers for Medicare & Medicaid Services Issued: February, 2013 Important Notice This training module
MEDICARE PLAN PAYMENT GROUP
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 MEDICARE PLAN PAYMENT GROUP Date: June 23, 2017 To: From: All Part
Community Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018
Title: and H2034 HMO-SNP 2018 Policy Identifier: PA - Pharmacy Effective Date: 20180101 Scope: Organization Wide Family Care PACE Partnership Waukesha Day Center HUD (Housing and Urban Development) Department:
APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1
APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 DECEMBER 2015 TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 DECEMBER 2015 APPENDIX B: VENDOR DRUG PROGRAM Table of
APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1
APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 APRIL 2018 TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 APRIL 2018 APPENDIX B: VENDOR DRUG PROGRAM Table of Contents
April 8, Dear Mr. Levinson,
April 8, 2019 Daniel Levinson Office of Inspector General Department for Health and Human Services Cohen Building, Room 5527 330 Independence Ave, SW Washington, DC 20201 Re: Fraud and Abuse; Removal of
DMHC Update CAHP Conference 2017
DMHC Update CAHP Conference 2017 Presented by: Shelley Rouillard, Director Marta Green, Chief Deputy Director Jenny Phillips, Legislative Affairs Deputy Director Mary Watanabe, Health Policy and Stakeholder
January 25, Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Outof-Pocket Expenses [CMS 4180 P] RIN 0938 AT92
![January 25, Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Outof-Pocket Expenses [CMS 4180 P] RIN 0938 AT92](/thumbs/88/117475723.jpg "January 25, Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Outof-Pocket Expenses [CMS 4180 P] RIN 0938 AT92")
January 25, 2019 [Submitted electronically via www.regulations.gov] The Honorable Seema Verma Administrator Centers for Medicare & Medicaid Services U.S. Department of Health and Human Services Attention:
Advanced Endocrinology and Weight Management Ritu Malik MD
PATIENT INFORMATION PERMANENT ADDRESS EMAIL: PHONE: Home Work Cell SEX M F AGE MARITAL STATUS M S D W SPOUSE NAME PATIENT SOCIAL SECURITY - - OCCUPATION EMPLOYER EMPLOYER ADDRESS EMERGENCY CONTACT NAME
Legislative Update HIPAA/HITECH
Legislative Update HIPAA/HITECH Richard C. Stevens, Attorney Martin, Pringle, Oliver, Wallace & Bauer, LLP http://martinpringle.com Topics Legislative Update HIPAA/HITECH q Enforcement Activities q Meaningful
Introduction Presentation: Elizabeth W. Woodcock, MBA, FACMPE, CPC Kareo Special Offer: Matt Kelly, Account Executive, Kareo Questions
Medical Billing Made Easy Presents Getting Paid in 2012: What You Need to Know Now to Make it Happen Beginning now Today s Program Introduction Presentation: Elizabeth W. Woodcock, MBA, FACMPE, CPC Kareo
EGWP Frequently Asked Questions For SSC & USG Benefits Administrators
EGWP Frequently Asked Questions For SSC & USG Benefits Administrators Q. Why is the USG utilizing a Medicare part D plan as part of their pharmacy coverage? A. Due to Health Care Reform, Pharmaceuticals
1 Security 101 for Covered Entities
HIPAA SERIES Topics 1. 101 for Covered Entities 2. Standards - Administrative Safeguards 3. Standards - Physical Safeguards 4. Standards - Technical Safeguards 5. Standards - Organizational, Policies &
The benefits of electronic claims submission improve practice efficiencies
The benefits of electronic claims submission improve practice efficiencies Electronic claims submission vs. manual claims submission An electronic claim is a paperless patient claim form generated by computer
Texas Vendor Drug Program. Pharmacy Provider Procedure Manual. Managed Care. Effective Date. November 2017
Texas Vendor Drug Program Pharmacy Provider Procedure Manual Managed Care Effective Date November 2017 The Pharmacy Provider Procedure Manual (PPPM) is available online at txvendordrug.com/about/policy/manual.
Provider Insider January 2017
Provider Insider January 2017 Happy New Year from Kaiser Permanente! Our new claims system is now live. The Epic product replaced our current claims system, allowing us to create end-to-end seamless access